Visceral metastasisDisease1 paperHuman trial1LatestThe Lancet Oncology·16 JunCombination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trialRandomised trial in 719 peopleBreast cancerPaper
The Lancet Oncology·16 JunCombination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trialRandomised trial in 719 peopleBreast cancerPaper